These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29104476)

  • 1. GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.
    Cai X; Li J; Wang M; She M; Tang Y; Li J; Li H; Hui H
    Int J Med Sci; 2017; 14(12):1203-1212. PubMed ID: 29104476
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-like peptide-1 attenuates liver injury in the rat diabetes model.
    Yang Z; Guo C; Ma J; Lu Y; Xuan L; Huang Y; Yang X; Zhao M; Luo Y
    Pak J Pharm Sci; 2019 Jan; 32(1(Supplementary)):309-313. PubMed ID: 30829208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction.
    Cai X; She M; Xu M; Chen H; Li J; Chen X; Zheng D; Liu J; Chen S; Zhu J; Xu X; Li R; Li J; Chen S; Yang X; Li H
    Int J Biol Sci; 2018; 14(12):1696-1708. PubMed ID: 30416384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
    Hernández C; Bogdanov P; Corraliza L; García-Ramírez M; Solà-Adell C; Arranz JA; Arroba AI; Valverde AM; Simó R
    Diabetes; 2016 Jan; 65(1):172-87. PubMed ID: 26384381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.
    Yang S; Lin C; Zhuo X; Wang J; Rao S; Xu W; Cheng Y; Yang L
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1019-E1030. PubMed ID: 32985256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
    Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway.
    Wei L; Mo W; Lan S; Yang H; Huang Z; Liang X; Li L; Xian J; Xie X; Qin Y; Lin F; Luo Z
    J Diabetes Res; 2022; 2022():1861940. PubMed ID: 36387940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy.
    Pang B; Zhou H; Kuang H
    Peptides; 2018 Feb; 100():123-126. PubMed ID: 28807775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.
    Fan Y; Liu K; Wang Q; Ruan Y; Zhang Y; Ye W
    Mol Vis; 2014; 20():1557-68. PubMed ID: 25489228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
    Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis.
    Kim DI; Park MJ; Choi JH; Lim SK; Choi HJ; Park SH
    Int J Biochem Cell Biol; 2015 Feb; 59():41-51. PubMed ID: 25483438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
    Fernandes R; Bento CF; Matafome P; Sena CM; Seiça RM; Pereira P
    Can J Physiol Pharmacol; 2014 Dec; 92(12):1037-43. PubMed ID: 25404034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
    Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
    Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactive response DNA binding protein of 43/histone deacetylase 6 axis alleviates H
    Yi EH; Xu F; Li P; Guo JQ
    J Cell Biochem; 2019 Mar; 120(3):4312-4320. PubMed ID: 30320895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagon-like peptide 1 improves learning and memory abilities of rats with type 2 diabetes].
    Tan ZG; Gao WH; Cai XS; Wang F; Hui HX
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1345-1351. PubMed ID: 27777196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study.
    Gaborit B; Julla JB; Besbes S; Proust M; Vincentelli C; Alos B; Ancel P; Alzaid F; Garcia R; Mailly P; Sabatier F; Righini M; Gascon P; Matonti F; Houssays M; Goumidi L; Vignaud L; Guillonneau X; Erginay A; Dupas B; Marie-Louise J; Autié M; Vidal-Trecan T; Riveline JP; Venteclef N; Massin P; Muller L; Dutour A; Gautier JF; Germain S
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31589290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-proteasome system and ER stress in the retina of diabetic rats.
    Shruthi K; Reddy SS; Reddy GB
    Arch Biochem Biophys; 2017 Aug; 627():10-20. PubMed ID: 28606465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
    Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
    Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.